Novel experimental models of hallucinogenic drug action, anxiety and depression--From fish to humans

Author(s):  
A. V. Kalueff ◽  
E. Kyzar ◽  
J. Cachat ◽  
S. Gaikwad ◽  
J. Green ◽  
...  
1981 ◽  
Vol 14 (3) ◽  
pp. 339-343 ◽  
Author(s):  
Francis J. White ◽  
Alice M. Holohean ◽  
James B. Appel

2014 ◽  
Vol 26 (5) ◽  
pp. 307-314 ◽  
Author(s):  
Fatma Sultan Kilic ◽  
Sule Ismailoglu ◽  
Bilgin Kaygisiz ◽  
Setenay Oner

BackgroundGabapentin, a third-generation antiepileptic drug, is a structural analogue of γ-aminobutyric acid, which is an important mediator of central nervous system. There is clinical data indicating its effectiveness in the treatment of psychiatric illnesses such as bipolar disorder and anxiety disorders.ObjectivesWe aimed to investigate the antidepressant and anxiolytic-like effects and mechanisms of gabapentin in rats.Material and MethodsFemale Spraque–Dawley rats weighing 250±20 g were used. A total of 13 groups were formed, each containing 8 rats: gabapentin (5, 10, 20, 40 mg/kg), amitriptyline (10 mg/kg), sertraline (5 mg/kg), diazepam (5 mg/kg), ketamine (10 mg/kg), gabapentin 20 mg/kg was also combined with amitriptyline (10 mg/kg), sertraline (5 mg/kg), diazepam (5 mg/kg) and ketamine (10 mg/kg). All the drugs were used intraperitoneally as single dose. Saline was administered to the control group. Elevated plus maze and forced swimming tests were used as experimental models of anxiety and depression, respectively.ResultsIt was observed that gabapentin showed an anxiolytic-like and antidepressant-like effect in all doses in rats. Its antidepressant effect was found to be the same as the antidepressant effects of amitriptyline and sertraline. There was no change in the antidepressant effect when gabapentin was combined with amitriptyline and ketamine, but there was an increase when combined with sertraline and diazepam. Gabapentin and amitriptyline showed similar anxiolytic effect, whereas ketamine and diazepam had more potent anxiolytic effect compared with them.ConclusionsThese data suggest that gabapentin may possess antidepressant- and anxiolytic-like effects.


Author(s):  
Nitin Lavate

Pharmacology, the science of drug action, has helped to elucidate many basic physiological and pathological mechanisms in health and disease. Various animal experimental models have been designed to study the effect of drugs on living organisms and isolated tissues. These give an insight about where and how a drug acts, the mode of action of a drug, its effect on various body systems and probable adverse effects before administration of a drug. Therefore, the object of pharmacology is to provide such scientific data in animals as well as humans, which forms the basis of rational therapeutics. The  Jalamahabhuta is fundamental base of origin for kapha  dosha and mootra. These are supposed to have Asray-Asrayi Sambandha . It means these are directly proportional to each other. So by using the drug which is having the mootrala property Kapha may be controlled. Here an effort is made to prove this concept with modern parameters like immunomodulation, anti-inflammatory and antihistaminic activity.  


1999 ◽  
Vol 142 (2) ◽  
pp. 215-220 ◽  
Author(s):  
Carmen Pérez-García ◽  
Lydia Morales ◽  
M. Victoria Cano ◽  
Isabel Sancho ◽  
L. F. Alguacil

Author(s):  
A. V. Kalueff ◽  
K. A. Demin ◽  
A. D. Volgin

Affective disorders — including anxiety and depression — are the most prevalent human brain diseases. Stress is the most common cause of these human psychopathologies, and is also often used to develop their experimental models in animals. In addition to genetic and environmental factors, genomic and epigenetic processes play an important role in affective pathogenesis. The aim of the present study is to examine the expression of brain genes in mice in the chronic 20-day social stress model developed by Prof. N.N. Kudryavtseva (Institute of Cytology and Genetics) and to experimentally test the hypothesis on ‘genes-integrators’ whose brain activity can specifically integrate anxiety-depressive mechanisms. The report will for the first time provide data on the existence of several such putative brain genes whose expression in the hippocampus and cortex changes dynamically as stress transitions from the «anxiety» (10 days) to the «depressive» phase (20 days), including a number of cytokine and cellular structural genes whose expression is specifically altered only in the «transitional» stage (15 days). The findings provide a new perspective on the complex genomics of the anxiety-depressive pathogenesis of the CNS, and can be translationally significant, including in terms of finding new potential targets for the therapy of anxiety and depression based on such ‘gene-integrators’.


2017 ◽  
Vol 36 (4) ◽  
pp. 215 ◽  
Author(s):  
AshokKumar Dubey ◽  
Snigdha Sharma ◽  
Shailendra Handu ◽  
Prashant Sharma ◽  
Pramod Mediratta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document